  See all
 |
Articles: Drug/Product Alerts |
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/15/09
Free full text
Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease
Genzyme, 06/15/09
Free full text
Methoxy polyethylene glycol-epoetin beta: worth waiting for or a novelty worn off
Expert Opinion in Pharmacotherapy, 06/12/09 Medtronic Receives FDA Approval for BRYAN Cervical Disc System
Medtronic, 06/12/09
Free full text
Solvay pharmaceuticals inc. has been informed of anda filing for generic androgel in the usa
Solvay, 06/11/09
Free full text
FDA actions in brief, June 2009 (Avastin, Azor, Exforge HCT, Cycloset, ACTOplus met XR, Lamictal ODT, Dysport, Creon)
Formulary, 06/11/09 Favorable vote from FDA Advisory Committee on SEROQUEL pediatric Supplemental New Drug Applications
AstraZeneca, 06/11/09
Free full text
Watson Files FDA Application for Generic Mucinex D
Watson Pharmaceuticals, 06/11/09
Free full text
U.S. FDA Issues Complete Response Letter for Rivaroxaban
BayNews International, 06/11/09
Free full text
Strativa's new drug application for ondansetron orally dissolving film strip accepted by fda
Par Pharmaceutical, 06/11/09 Certolizumab pegol (Cimzia): Anti-TNF-alpha mAb approved for the treatment of rheumatoid arthritis
Formulary, 06/10/09 Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/10/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/09/09
Free full text
Iloperidone (Fanapt): Psychotropic agent approved for the acute treatment of schizophrenia
Formulary, 06/08/09 World Health Organization grants Global Prequalification to GSK's Rotarix vaccine
GlaxoSmithKline, 06/08/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/08/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/05/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/04/09
Free full text
FDA advisory panel makes favorable recommendation for ARZERRA (ofatumumab)
GlaxoSmithKline, 06/02/09
Free full text
FDA approves Reclast to prevent osteoporosis in postmenopausal women with convenient less frequent dosing
Novartis, 06/02/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
144 Available Pages
|
|
